{"doi":"10.3126/jdean.v1i1.21191","title":"Response to Cabergoline treatment in Invasive Prolactinoma with hemorrhage- A case report","abstract":"<jats:p>Patients with invasive prolactinoma present with constellation of symptoms including headache, blurred vision, lethargy, menstrual irregularity and sexual dysfunction. Cabergoline, a potent dopamine agonist, is a known medication prescribed for the treatment of prolactinoma. Here, we report a case of invasive macroprolactinoma with hemorrhage in a 18 years female with dramatic response to cabergoline treatment clinically, biochemically, and radiologically.Jour of Diab and Endo Assoc of Nepal 2017; 1(1): 18-20</jats:p>","journal":"Journal of Diabetes and Endocrinology Association of Nepal","year":2018,"id":41945,"datarank":0.18616719057473186,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"self_citation_contribution":0.16479184330021646,"citation_network_contribution":0.021375347274515392,"self_endowment_contribution":0.16479184330021646,"citer_contribution":0.021375347274515392,"corpus_percentile":null,"corpus_rank":null,"citation_count":2,"citer_count":2,"citers_with_citation_signal":1,"citers_with_endowment":1,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":201402,"name":"Suman Baral","orcid":null,"position":1,"is_corresponding":false},{"id":201403,"name":"Binod Aryal","orcid":null,"position":2,"is_corresponding":false},{"id":201404,"name":"Arjun Tumbapo","orcid":null,"position":3,"is_corresponding":false},{"id":201401,"name":"Vivek Pant","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"18998881","pmcid":null,"openalex_id":"https://openalex.org/W2894413773","authors":[],"funders":[],"total_grants":0,"fwci":0.0,"citation_percentile":0.17644609,"influential_citations":0,"citation_trend":[{"year":2024,"count":1},{"year":2026,"count":1}],"oa_status":"gold","license":"http://creativecommons.org/licenses/by-nc/4.0","oa_locations":[{"url":"https://www.nepjol.info/index.php/jdean/article/download/21191/17352","host_type":"journal"},{"url":"https://www.nepjol.info/index.php/jdean/article/download/21191/17352","host_type":"GOLD"},{"url":"https://www.nepjol.info/index.php/jdean/article/download/21191/17352","host_type":"publisher"},{"url":"https://doi.org/10.3126/jdean.v1i1.21191","host_type":"journal"}],"fields_of_study":["Pituitary Gland Disorders and Treatments","Adrenal and Paraganglionic Tumors","Neuroendocrine Tumor Research Advances","Medicine"],"mesh_terms":[],"keywords":["Cabergoline","Prolactinoma","Medicine","Dopamine agonist","Lethargy","Agonist","Internal medicine","Prolactin"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-13T16:19:15.389744Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}